Become A Featured Company

Gabriella’s Kitchen Is Redefining The Cannabis Health and Wellness Industry

Ryan Allway

November 12th, 2018

News, Top Story

Gabriella’s Kitchen (CSE: GABY), the award-winning consumer packaged goods company whose array of super-nutritional foods are currently sold in more than 3,400 stores across North America, is launching a revolutionary new line of cannabis infused nutritional edibles. The expansion as well as a number of announced acquisitions has positioned the company on the cutting edge of cannabis infused nutritional edibles and therapeutic products, further accelerating GABY’s mission, “to empower people to live healthy lives without compromise.”  

Passionate Mission

GABY, founded by sisters Gabriella and Margot Micallef, was inspired by Gabriella’s terminal cancer diagnosis. Though Gabriella ultimately passed away from her illness, she beat her 4 month prognosis by an exponential factor of 10 and enjoyed a much higher quality of life than her doctors predicted. According to Margot Micallef, Founder & CEO of GABY, “The experience of Gabriella’s journey with cancer confirmed our views that diet and lifestyle is a real alternative to pharma and often with better results!”

GABY’s passionate mission has been furthered by the launch of its cannabis infused edibles  which are now in market in California under the alto™ brand. Uninfused versions of the same alto™ edibles are also available online at www.Gabriellas-kitchen.com. In addition, GABY has another 20 uninfused products in market in California and throughout the US and Canada in thousands of mainstream retailers, creating a fast-track to the mainstream retail market for its soon to be launched Hemp-CBD infused edibles.

Expansion Into Cannabis Infused Edibles & Wellness Products

Given the importance of California as both a cannabis and a wellness market, GABY determined it was crucial to own its infrastructure in California. Therefore, in September, Gabriella’s Kitchen acquired The Oil Plant, Inc. (TOP), the owner of a Type 6 manufacturing license issued by the California Bureau of Cannabis Control (CBCC). In October, GABY announced the acquisition of Sonoma Pacific Distribution, one of California’s leading independently owned cannabis distribution and marketing companies with a distribution and transport license issued by CBCC. With these acquisitions and with GABY’s vast and deep retail and consumer packaged goods experience, GABY has one of the most reliable and fastest go to market strategies of any cannabis company trading today. Uniquely, while others rely on third party relationships, GABY has the advantage of having direct control over the development, manufacturing, distribution and sale of its cannabis products in the world’s most important market.  

Through these acquisitions GABY also acquired the benefit of TOP’s best in class cannabis oil extraction technology and TOP’s interest in the market-leading brand of Aunt Zelda’s™ topicals and tinctures. The products are featured in the film Weed the People – a documentary by the renowned film production team of Abby Epstein and Ricki Lake.   

Cannabinoids are unique organic compounds commonly found in the cannabis plant. In multiple studies, both cannabidiol (CBD) and tetrahydrocannabinol (THC) have proven to have powerful wellness properties, including pain relief, inflammation relief, sleep enhancements, and general wellness. The combination of GABY’s move into CBD- and THC-infused edibles and lifestyle products, together with its recent acquisitions, brings the necessary expertise, access to capital, and infrastructure necessary to create a category leader in cannabis wellness.  

Consumers are flocking to CBD and THC infused products, a market segment that is expected to greatly exceed expenditures for recreational marijuana use. In 2018, just six months after statewide legalization of cannabis for adult use, California consumers spent $1.14 billion on products through 600 licensed cannabis dispensaries. According to Arcview Market Research, the California cannabis industry is predicted to exceed $7.7 billion by 2021– establishing the state as the largest cannabis market in the world.

In addition to the California market GABY has its eyes on the remaining states in the US and on Canada, where its alto™ and Aunt Zelda’s™ products can be sold. According to Cowen & Co., the North American cannabis industry will reach $75 billion by 2030. GABY is positioning itself to participate in this expanded market, and the timing couldn’t be better.

Sophisticated investors are looking beyond the stunning market appreciation of cannabis producers and cultivators to focus on the next wave of cannabis – related startups, namely those industry participants that are downstream of cultivation – manufacturers, distributors and dispensaries.  

GABY may have found the recipe to soar in the multi-billion-dollar THC and CBD based healthy edibles and wellness industry. This market segment is rapidly becoming the growth driver in the cannabis industry as well as the trillion-dollar health and wellness sector.

With significant distribution infrastructure already in place, a proven agility to obtain regulatory clearance, and a tasty portfolio of healthy and therapeutic revenue opportunities, GABY is transitioning into a highly focused, vertically integrated edibles and wellness products company.  

The Strategy Forward

GABY’s successful acquisition of TOP also brought GABY the benefit of Mara Gordon, the founder of TOP who on closing took on the role of Chief Research Officer at GABY. Ms. Gordon brings to GABY her extensive knowledge of the health attributes associated with cannabis and her expertise in formulations. GABY believes that to be the category leader in cannabis wellness it must also be a thought leader. In her role as Chief Research Officer, Ms. Gordon will continue her research into cannabis wellness and education and will continue her work with physicians and clinicians studying cannabis wellness. She will also continue to speak at medical conferences, before policy committees, at industry events and to consumers and retailers to educate, inform and collaborate on the advancement of cannabis wellness.  

GABY is not just well positioned to take advantage of the current market opportunities but is looking beyond the immediate to a time when federal legalization in the US removes the barriers to inter-state commerce. At such time, GABY’s existing infrastructure of major retailers and its distribution networks in both the licensed and unlicensed channels positions the company to rapidly expand into a wide variety of stores across North America with CBD and THC infused products.

Through the first half of 2018 GABY’s revenue rose by 171 percent to approximately $1.2MM, from $450,000 in the first half of 2017. Further growth is expected during the second half of the year following the launch of its alto™ product line as well as from its continuing roll up strategy. TOP’s existing management team projected revenue of US$10 million in 2019, Sonoma is anticipating $7.6 million. With the launch of six cannabis-related products as the foundation of GABY’s continued product development strategy, these unique factors could boost consolidated 2019 annual revenue to ~US$26.7 million (~C$35 million).

Gabriella’s Kitchen (CSE: GABY) has successfully transitioned into one of the only publicly-trading, pure play cannabis edibles and wellness companies listed on the CSE. Investors interested in the intersection between the multibillion-dollar cannabis industry and the trillion-plus dollar wellness industry may want to take a closer look at the company as it gears up to launch additional cannabis infused edibles and wellness products this year while continuing its roll up strategy of acquiring related and complementary companies in this sector.

For more information, visit the company’s website at www.gabriellas-kitchen.com.   

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading